210 related articles for article (PubMed ID: 8704244)
1. Venous thromboembolism associated with double heterozygosity for R506Q mutation of factor V and for T298M mutation of protein C in a large family of a previously described homozygous protein C-deficient newborn with massive thrombosis.
Brenner B; Zivelin A; Lanir N; Greengard JS; Griffin JH; Seligsohn U
Blood; 1996 Aug; 88(3):877-80. PubMed ID: 8704244
[TBL] [Abstract][Full Text] [Related]
2. Activated protein c resistance (APC) and inherited factor V (FV) mis-sense mutation in patients with venous and arterial thrombosis in a haematology clinic.
Ma DD; Aboud MR; Williams BG; Isbister JP
Aust N Z J Med; 1995 Apr; 25(2):151-4. PubMed ID: 7605298
[TBL] [Abstract][Full Text] [Related]
3. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families.
Koeleman BP; Reitsma PH; Allaart CF; Bertina RM
Blood; 1994 Aug; 84(4):1031-5. PubMed ID: 8049422
[TBL] [Abstract][Full Text] [Related]
4. The factor VR506Q mutation causing APC resistance is highly prevalent amongst unselected outpatients with clinically suspected deep venous thrombosis.
Svensson PJ; Zöller B; Mattiasson I; Dahlbäck B
J Intern Med; 1997 May; 241(5):379-85. PubMed ID: 9183305
[TBL] [Abstract][Full Text] [Related]
5. Pseudo-homozygous activated protein C resistance due to coinheritance of heterozygous factor V Leiden mutation and type I factor V deficiency. Variable expression when analyzed by different activated protein C resistance functional assays.
Delahousse B; Iochmann S; Pouplard C; Fimbel B; Charbonnier B; Gruel Y
Blood Coagul Fibrinolysis; 1997 Nov; 8(8):503-9. PubMed ID: 9491268
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of a type I quantitative factor V deficiency in a thrombosis patient that is "pseudo homozygous" for activated protein C resistance.
Guasch JF; Lensen RP; Bertina RM
Thromb Haemost; 1997 Feb; 77(2):252-7. PubMed ID: 9157576
[TBL] [Abstract][Full Text] [Related]
7. [Severe hereditary coagulation factor V deficiency caused by two novel heterozygous mutations].
Zhou RF; Fu QH; Xu XC; Wang WB; Wu WM; Ding QL; Xie S; Zhai ZM; Hu YQ; Wang XF; Wu JS; Wang HL
Zhonghua Xue Ye Xue Za Zhi; 2005 Mar; 26(3):129-32. PubMed ID: 15946520
[TBL] [Abstract][Full Text] [Related]
8. An underestimated combination of opposites resulting in enhanced thrombotic tendency.
Simioni P; Castoldi E; Lunghi B; Tormene D; Rosing J; Bernardi F
Blood; 2005 Oct; 106(7):2363-5. PubMed ID: 15961511
[TBL] [Abstract][Full Text] [Related]
9. The significance of F139V mutation on thrombotic events in compound heterozygous and homozygous protein C deficiency.
Yang LH; Zheng FX; Chen Y; Jin YH; Zhang Z; Xie HX; Yang XL; Wang MS; Chen BC
Blood Coagul Fibrinolysis; 2014 Dec; 25(8):824-30. PubMed ID: 24911457
[TBL] [Abstract][Full Text] [Related]
10. Hereditary protein C deficiency caused by the Ala267Thr mutation in the protein C gene is associated with symptomatic and asymptomatic venous thrombosis.
Tjeldhorn L; Sandset PM; Haugbro K; Skretting G
Thromb Res; 2010 Mar; 125(3):230-4. PubMed ID: 19535131
[TBL] [Abstract][Full Text] [Related]
11. High risk of thrombosis recurrence in patients with homozygous and compound heterozygous factor V R506Q (Factor V Leiden) and prothrombin G20210A.
Federici EH; Al-Mondhiry H
Thromb Res; 2019 Oct; 182():75-78. PubMed ID: 31472339
[TBL] [Abstract][Full Text] [Related]
12.
Gemmati D; Longo G; Franchini E; Araujo Silva J; Gallo I; Lunghi B; Moratelli S; Maestri I; Serino ML; Tisato V
Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34207366
[TBL] [Abstract][Full Text] [Related]
13. Probability of recurrence of thrombosis in patients with and without factor V Leiden.
Rintelen C; Pabinger I; Knöbl P; Lechner K; Mannhalter C
Thromb Haemost; 1996 Feb; 75(2):229-32. PubMed ID: 8815565
[TBL] [Abstract][Full Text] [Related]
14. The factor V gene A4070G mutation and the risk of venous thrombosis.
Alhenc-Gelas M; Nicaud V; Gandrille S; van Dreden P; Amiral J; Aubry ML; Fiessinger JN; Emmerich J; Aiach M
Thromb Haemost; 1999 Feb; 81(2):193-7. PubMed ID: 10063990
[TBL] [Abstract][Full Text] [Related]
15. Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency.
van Boven HH; Reitsma PH; Rosendaal FR; Bayston TA; Chowdhury V; Bauer KA; Scharrer I; Conard J; Lane DA
Thromb Haemost; 1996 Mar; 75(3):417-21. PubMed ID: 8701400
[TBL] [Abstract][Full Text] [Related]
16. Factor V Leiden: an additional risk factor for thrombosis in protein S deficient families?
Koeleman BP; van Rumpt D; Hamulyák K; Reitsma PH; Bertina RM
Thromb Haemost; 1995 Aug; 74(2):580-3. PubMed ID: 8584987
[TBL] [Abstract][Full Text] [Related]
17. [Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population].
Ehrenforth S; Klinke S; von Depka Prondzinski M; Kreuz W; Ganser A; Scharrer I
Dtsch Med Wochenschr; 1999 Jun; 124(25-26):783-7. PubMed ID: 10414227
[TBL] [Abstract][Full Text] [Related]
18. Discrimination between normal wildtype and carriers of coagulation factor V Leiden mutation by the activated protein C resistance test in the presence of factor V deficient plasma.
Reuner KH; Litfin F; Patscheke H
Eur J Clin Chem Clin Biochem; 1997 Jan; 35(1):41-5. PubMed ID: 9156566
[TBL] [Abstract][Full Text] [Related]
19. Factor V R506Q gene mutation analysis by PCR-RFLP: optimization, comparison with functional testing for resistance to activated protein C, and establishment of cell line controls.
Voelkerding KV; Wu L; Williams EC; Hoffman SM; Sabatini LM; Borcherding WR; Huber S
Am J Clin Pathol; 1996 Jul; 106(1):100-6. PubMed ID: 8701917
[TBL] [Abstract][Full Text] [Related]
20. Legg-Calve-Perthes disease, venous and arterial thrombi, and the factor V Leiden mutation in a four-generation kindred.
Glueck CJ; Tracy T; Wang P
J Pediatr Orthop; 2007; 27(7):834-7. PubMed ID: 17878795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
